Periconception Maternal-Serum Vitamin D, Vaginal Bleeding, and Subchorionic Hemorrhage in Early Pregnancy
Alkhalaf ZM, Mumford SL, Schisterman EF, Silver RM, Thoma ME
Nutrients · 0 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Según 1 financiador declarado y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2026-07-16 · Nutrients · vol. 18 · número 14 · pág. 2339
- Editorial
- Multidisciplinary Digital Publishing Institute
- Citado
- 0 citas · más que el 54% de estudios similares · 0.0× el promedio de su campo
- Referencias
- 0 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Vitamin D Research Studies · Pregnancy and preeclampsia studies · Pregnancy and Medication Impact
- Palabras clave
- vitamin D, 25-hydroxyvitamin D, subchorionic hemorrhage, vaginal bleeding, early pregnancy, vitamin D deficiency, miscarriage, EAGeR trial, placental development, implantation
- MeSH
- humans, uterine hemorrhage, pregnancy complications, vitamin d deficiency, vitamin d, logistic models, risk factors, prospective studies, pregnancy, pregnancy trimester, first, adult, female, young adult
5 autores
- Zeina Alkhalaf🇺🇸 · autor de correspondenciaUniversity of Maryland, College Park
- Sunni L. Mumford🇺🇸University of Pennsylvania
- Enrique F. Schisterman🇺🇸University of Pennsylvania
- Robert M. Silver🇺🇸University of Utah
- Marie E. Thoma🇺🇸University of Maryland, College Park
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background/Objectives: To examine relationships between maternal-serum 25(OH)D levels at preconception and 8 weeks' gestation and the risk of vaginal bleeding and subchorionic hemorrhage during pregnancy. Methods: A secondary analysis of the EAGeR Trial, which is a prospective, multisite, randomized controlled trial that enrolled 1228 women with 1-2 prior pregnancy losses. Analyses were restricted to participants who became pregnant and had 25(OH)D measured at preconception (n = 747) and 8 weeks' gestation (n = 605). Vaginal bleeding and subchorionic hemorrhage were assessed via medical record extraction, which captured clinically recognized symptoms at medical visits measured at any point throughout pregnancy. Symptom severity of vaginal bleeding was assessed via time-varying self-reported symptoms across early pregnancy through 3-8 weeks gestation using daily diaries. Logistic regression models evaluated associations between maternal-serum 25(OH)D levels (deficient ≤ 20 ng/mL; insufficient 21-29 ng/mL; sufficient ≥ 30 ng/mL) and vaginal bleeding and subchorionic hemorrhage, while generalized estimating equations (GEE) models were used to evaluate time-varying symptom severity of vaginal bleeding from daily diary data. Results: Those who remained 25(OH)D deficient/insufficient had increased odds of having a subchorionic hemorrhage (aOR: 2.18; 95% CI: 1.13, 4.20) compared to those who had sufficient levels at both time points. In longitudinal GEE models, women with deficient preconception 25(OH)D had greater odds of moderate-to-heavy bleeding (vs. none) (aOR: 3.02; 95% CI: 1.13, 8.13), but no association was observed for light bleeding (aOR: 1.07; 95% CI: 0.58, 2.00). Findings were directionally similar, yet less precise when restricted to pregnancies resulting in a live birth. Conclusions: Persistently low vitamin D from preconception to early pregnancy is associated with increased risk of subchorionic hemorrhage and moderate/heavy vaginal bleeding, highlighting the importance of vitamin D sufficiency for implantation and early placental development.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.